Management of MetS risk factors The metabolic risk variables in the syndromes definition include atherogenic dyslipidemia, elevated blood pressure, high plasma glucose, a prothrombotic condition, and a pro-inflammatory state ( Reduction in blood pressure has been demonstrated to reduce the risk of severe CVD in several clinical studies, including those involving people with type-2 diabetes ( A prothrombotic state is indicated by elevated levels of fibrinogen, plasminogen activator inhibitor-1, and other coagulation components
In conclusion, non-pharmacological therapies that focus on controlling the etiology of liver disease, improving nutrition, increasing muscle mass, mitigating triggers and risk factors, and enhancing coping mechanisms are significantly more effective in combating fatigue in cirrhosis compared to pharmacological treatments (Figure 2) (4, 9)
Both melanotan I and melanotan II are not included on the Australian Register of Therapeutic Goods (ARTG)
It is intended strictly for in vitro studies , animal models , or regulated laboratory research
